Health

Results: 193-204 of 6686

EADV Congress 2025: GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

PR Newswire associated0

SAM Medical expands emergency medical offering with strategic acquisition of TyTek Medical

Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

Are Women on the Frontline of Antimicrobial Resistance?

PR Newswire associated0

Esaote opens new offices in Maastricht and reaffirms its presence in the Netherlands with business development plans and investments in human capital

Crown Bioscience celebrate the official ribbon-cutting ceremony for the company’s new Kannapolis, North Carolina facility, marking an expansion of US oncology model development and preclinical CRO services.

Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina

First group of Gazan children arrive for specialist NHS treatment

Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board

Continuous Patient Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs

PR Newswire associated0

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model “Hada no Aozora Clinic” Establishment

Travis Besanger, Kinectrics VP of Medical Isotopes, speaking within the new Isotope Separation Production Facility at Kinectrics Headquarters in Toronto, Canada.

Kinectrics Significantly Increases Isotope Production Capacity to Meet Growing Global Demand